Chris Schott Analyst Performance

Analyst at JPMorgan Chase & Co.

Chris Schott is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 24 publicly traded companies. Over the past year, Chris Schott has issued 45 stock ratings, including buy and hold recommendations. While full access to Chris Schott's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Chris Schott's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
137 Last 11 Years
Buy Recommendations
72.09% 93 Buy Ratings
Companies Covered
24 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy72.1%93 ratings
Hold25.6%33 ratings
Sell2.3%3 ratings

Out of 129 total stock ratings issued by Chris Schott at JPMorgan Chase & Co., the majority (72.1%) have been Buy recommendations, followed by 25.6% Hold and 2.3% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
12 companies
NASDAQ
50.0% of companies on NASDAQ
12 companies

Chris Schott, an analyst at JPMorgan Chase & Co., currently covers 24 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
24 companies
100.0%

Chris Schott of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
16 companies
66.7%
BIOTECHNOLOGY
7 companies
29.2%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
4.2%

Chris Schott's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
11/9/2026Boost Price Target$26.90$35.00Overweight
Viatris Inc. stock logo
VTRS
Viatris
11/6/2026Boost Price Target$19.91$21.00Neutral
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
11/4/2026Boost Price Target$19.90$25.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
11/4/2026Boost Price Target$476.70$425.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/30/2026Boost Price Target$1,415.64$1,650.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
10/30/2026Boost Price Target$149.75$175.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/30/2026Boost Price Target$170.68$190.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/30/2026Boost Price Target$927.89$1,050.00Overweight
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
10/22/2026Boost Price Target$20.34$24.00Overweight
Viatris Inc. stock logo
VTRS
Viatris
10/21/2026Boost Price Target$18.66$20.00Neutral
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10/16/2026Lower Price Target$565.43$750.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
10/12/2026Upgrade$225.71$300.00Overweight
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
10/12/2026Boost Price Target$40.68$50.00Overweight
Pfizer Inc. stock logo
PFE
Pfizer
10/9/2026Boost Price Target$28.24$30.00Neutral
AbbVie Inc. stock logo
ABBV
AbbVie
10/8/2026Boost Price Target$272.20$300.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/7/2026Boost Price Target$147.83$170.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/6/2026Boost Price Target$733.78$950.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
10/5/2026Boost Price Target$139.84$165.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/29/2026Boost Price Target$270.75$285.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
9/28/2026Boost Price Target$1,184.38$1,500.00Overweight
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
8/26/2026Initiated Coverage$17.98$22.00Overweight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
8/7/2026Boost Price Target$57.10$62.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
8/7/2026Lower Price Target$72.62$115.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/5/2026Boost Price Target$147.06$150.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/31/2026Boost Price Target$65.13$73.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
7/30/2026Boost Price Target$266.38$285.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
7/13/2026Boost Price Target$123.76$140.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
7/9/2026Boost Price Target$252.98$280.00Overweight
Pfizer Inc. stock logo
PFE
Pfizer
7/8/2026Lower Price Target$24.26$28.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/7/2026Boost Price Target$1,200.89$1,400.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/18/2026Lower Price Target$625.55$850.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
5/8/2026Lower Price Target$81.86$130.00Overweight
Viatris Inc. stock logo
VTRS
Viatris
5/8/2026Boost Price Target$16.84$18.00Neutral
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
5/7/2026Boost Price Target$24.04$30.00Overweight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
5/7/2026Boost Price Target$50.11$58.00Overweight
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
4/30/2026Boost Price Target$35.03$40.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4/6/2026Boost Price Target$120.73$135.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
3/5/2026Boost Price Target$238.61$250.00Neutral
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2/19/2026Boost Price Target$24.97$28.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/11/2026Boost Price Target$147.23$160.00Overweight
You missed yesterday's deadline… (Ad)

In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel

See which company controls this entire energy discovery now.
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/5/2026Boost Price Target$1,035.27$1,300.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2/2/2026Boost Price Target$752.06$950.00Overweight
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
12/16/2025Boost Price Target$30.02$35.00Overweight
Perrigo Company plc stock logo
PRGO
Perrigo
12/15/2025Lower Price Target$12.85$18.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
11/18/2025Boost Price Target$1,026.30$1,150.00Overweight
Organon & Co. stock logo
OGN
Organon & Co.
11/11/2025Lower Price Target$7.38$12.00Underweight
Perrigo Company plc stock logo
PRGO
Perrigo
11/6/2025Reiterated Rating$15.06$20.00Neutral
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
11/6/2025Boost Price Target$24.41$28.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
11/5/2025Lower Price Target$120.47$200.00Overweight
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11/4/2025Boost Price Target$716.71$775.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
11/3/2025Boost Price Target$217.86$260.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/31/2025Boost Price Target$119.00$150.00Overweight
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
10/7/2025Upgrade$20.68$24.00Overweight
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
10/3/2025Boost Price Target$20.05$26.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
9/16/2025Boost Price Target$112.54$145.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
9/16/2025Lower Price Target$748.26$1,050.00Overweight
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
9/16/2025Boost Price Target$9.79$14.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
9/16/2025Boost Price Target$217.92$235.00Overweight
Perrigo Company plc stock logo
PRGO
Perrigo
8/7/2025Lower Price Target$22.83$35.00Overweight
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
8/4/2025Boost Price Target$682.78$675.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
6/9/2025Lower Price Target$502.10$800.00Overweight
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
5/12/2025Upgrade$16.94$23.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
5/5/2025Lower Price Target$123.14$175.00Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
3/31/2025Lower Price Target$634.04$1,000.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
3/27/2025Boost Price Target$111.01$130.00Overweight
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
2/24/2025Upgrade$7.83$12.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/29/2025Boost Price Target$93.85$115.00Overweight